CN219847085U - Negative pressure release type compression hemostasis application - Google Patents
Negative pressure release type compression hemostasis application Download PDFInfo
- Publication number
- CN219847085U CN219847085U CN202321123609.9U CN202321123609U CN219847085U CN 219847085 U CN219847085 U CN 219847085U CN 202321123609 U CN202321123609 U CN 202321123609U CN 219847085 U CN219847085 U CN 219847085U
- Authority
- CN
- China
- Prior art keywords
- layer
- negative pressure
- hemostatic
- antibacterial
- pressure release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000023597 hemostasis Effects 0.000 title claims abstract description 32
- 230000006835 compression Effects 0.000 title claims abstract description 25
- 238000007906 compression Methods 0.000 title claims abstract description 25
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 66
- 239000011248 coating agent Substances 0.000 claims abstract description 35
- 238000000576 coating method Methods 0.000 claims abstract description 35
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 26
- 238000002955 isolation Methods 0.000 claims abstract description 10
- 230000001681 protective effect Effects 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 229940124350 antibacterial drug Drugs 0.000 claims abstract description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 241001330002 Bambuseae Species 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- 229960003276 erythromycin Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 229920002545 silicone oil Polymers 0.000 claims description 2
- 229920000049 Carbon (fiber) Polymers 0.000 claims 1
- 239000004917 carbon fiber Substances 0.000 claims 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 38
- 208000027418 Wounds and injury Diseases 0.000 abstract description 38
- 230000003749 cleanliness Effects 0.000 abstract description 6
- 238000009423 ventilation Methods 0.000 abstract description 3
- 206010051077 Post procedural haemorrhage Diseases 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 75
- 239000011505 plaster Substances 0.000 description 19
- 230000001105 regulatory effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002346 layers by function Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- WMOTVIKCLHJGCF-UHFFFAOYSA-N 2-aminoethanesulfonic acid phenol Chemical compound S(=O)(=O)(O)CCN.C1(=CC=CC=C1)O WMOTVIKCLHJGCF-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- -1 includes skin Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model belongs to the technical field of medical equipment, and discloses a negative pressure release type compression hemostasis application, which sequentially comprises an outer layer, a middle layer, an inner layer and an antibacterial hemostasis coating from top to bottom, wherein the periphery of the outer layer is connected with a binding belt; the middle layer is a sterile high-density high-elasticity sponge in a negative pressure state, the middle layer is communicated with a first valve, the middle layer is provided with an adjusting cavity which is in a shape of a trapezoid with a big top and a small bottom, an air bag is adhered to the adjusting cavity, and the air bag is communicated with a second valve; the inner layer is an isolation layer, the lower side of the inner layer is a ventilation isolation layer, and the upper side of the inner layer is a waterproof layer; the antibacterial hemostatic coating contains antibacterial drugs and hemostatic drugs, and a protective film is adhered to the lower side of the antibacterial hemostatic coating; the utility model solves the problems of complicated application and operation, high requirements on the cleanliness and flatness of the periphery of the wound and the hemostasis by relying on negative pressure equipment in the prior art, and is suitable for the compression hemostasis of the postoperative bleeding wound and the emergency hemostasis of outdoor or field superficial wounds.
Description
Technical Field
The utility model relates to the technical field of medical equipment, in particular to a negative pressure release type compression hemostasis application.
Background
How to safely and effectively stop bleeding has been an important component of clinical treatment, and development of hemostatic devices and methods has been a powerful impetus for promoting clinical medicine, especially the development of surgery. In the surgical field, reliable hemostasis is a necessary guarantee for the life safety of surgical patients; secondly, the bleeding and the hematocele of the wound in the operation area are reduced, which is beneficial to wound healing and reduces infection; in addition, blood transfusion due to blood loss is reduced or avoided, transmission of certain diseases can be prevented, and economic burden of patients is reduced. At present, the general application of gauze is used for filling or the gauze is used for covering the wound and then the adhesive tape is fixed so as to achieve the aim of hemostasis by compression after the operation, but the operation is more complicated, the function is single, more use requirements can not be met, and the operation is easy to fall off.
In order to solve the problems, chinese patent (patent publication No. CN 214907562U) discloses an adsorption type wound hemostatic plaster which comprises a base plaster, wherein a functional area is arranged on the base plaster, an adsorption cotton frame is fixedly connected to the bottom surface of the functional area, a functional layer is arranged in the adsorption cotton frame, the functional layer comprises an absorption layer, a seaweed salt layer and a ventilation isolation layer which are sequentially distributed from top to bottom, a hollow silica gel ring is fixedly connected to the middle part of the surface of the functional area, a plurality of adsorption holes penetrating the functional layer are formed in the bottom surface of the silica gel ring, an air channel opening is formed in one side of the silica gel ring, rubber is filled in the air channel opening, a negative pressure suction mechanism is detachably connected to adsorb gas in the base plaster, a connecting seat is arranged in the silica gel ring, a dosing cavity is also arranged in the connecting seat, a section of rubber is detachably connected to the dosing mechanism to inject medicine into the dosing cavity, and the adhesive is distributed around the adsorption cotton frame.
According to the scheme, the negative pressure suction mechanism is connected with the air duct opening, air between the skin and the base patch is pumped out through the adsorption hole, negative pressure is formed in the base patch, the base patch is attached to a wound function layer to be attached to the wound, and the function layer is used for adsorbing blood and stopping bleeding; however, the hemostatic plaster is attached in a negative pressure mode, high requirements are made on the cleanliness and flatness of the wound surface, and if impurities (such as blood stains and the like) exist around the wound or are located at uneven positions (such as joints and the like), the base plaster and the wound are difficult to form a closed space, so that effective attachment is difficult to realize; the hemostatic plaster can realize negative pressure by means of negative pressure equipment, is only suitable for clinical hemostasis, and is difficult to be applied to outdoor or outdoor emergency hemostasis. Therefore, there is a need for an application that is easy to operate, has low requirements for cleanliness and flatness of hemostatic wounds, does not rely on other equipment, and can be used for outdoor or field emergency hemostasis.
Disclosure of Invention
The utility model aims to provide a negative pressure release type compression hemostasis application, which aims to solve the problems that the prior hemostasis application is complex in use and operation, high in requirements on cleanliness and flatness around wounds, hemostasis can be realized by relying on negative pressure equipment, and outdoor or field emergency hemostasis is difficult to be applied.
In order to achieve the above object, the present utility model provides the following technical solutions:
the basic technical scheme provided by the utility model is as follows: the utility model provides a negative pressure release formula hemostasis by compression is applied ointment or plaster, includes skin, intermediate level, inlayer and antibiotic hemostatic coating from outside-in proper order, the intermediate level is the sponge that is in the negative pressure state, the intermediate level intercommunication has first valve, first valve is located the outside of skin, the inlayer is the insulating layer, antibiotic hemostatic coating's inboard still bonds there is the protection pad pasting.
The principle of the basic technical scheme is as follows: the protective film is used for protecting the antibacterial hemostatic coating when not in use, the antibacterial hemostatic coating is in contact with a wound, the inner layer isolates the antibacterial hemostatic coating from the sponge of the middle layer, and the outer layer is used for protecting the middle layer; when the hemostatic dressing is used, the protective film is uncovered, the whole hemostatic dressing is fixed on a wound by using the binding belt, the first valve is opened, the middle layer sponge in a negative pressure state expands after being inhaled, and the fixing effect of the binding belt on the whole dressing is unchanged, so that the hemostatic dressing is compression-hemostatic to the wound.
The basic technical scheme has the beneficial effects that: the hemostatic plaster has simple structure, convenient operation and low requirements on the cleanliness and flatness of the periphery of the wound, and can be suitable for compression hemostasis of superficial wounds and postoperative bleeding wounds; in addition, the negative pressure suction of the middle layer sponge is completed when the hemostatic plaster is prepared, so that the sponge expansion compression hemostasis can be realized without other equipment when the hemostatic plaster is used, and the hemostatic plaster can be suitable for emergency hemostasis of outdoor or outdoor superficial wounds.
Preferably, the middle layer is provided with an adjusting chamber, the adjusting chamber is in a trapezoid shape with a large upper part and a small lower part, and the lower end face of the adjusting chamber is flush with the upper end face of the inner layer.
Through the arrangement, the middle layer is provided with the trapezoid chamber with the upper part and the lower part, when the middle layer sponge in the negative pressure state is in inspiration expansion, oblique downward extrusion force is formed along the two oblique central hypotenuses of the trapezoid, so that the antibacterial hemostatic coating further presses the wound, and hemostasis and healing of the wound are facilitated.
Preferably, an air bag is adhered to the inner side wall of the regulating chamber, the lower surface of the air bag is adhered to the upper end face of the inner layer, the air bag is communicated with a second valve, and the second valve is arranged on the outer side of the outer layer.
Through the setting, the gasbag is in the state of aerifing pressurization when not using, extrudes the intermediate level sponge that will be in the negative pressure state to both sides, when using this hemostasis application, opens the second valve and makes the gasbag gassing shrink, combines the intermediate level sponge that is in the negative pressure state to inhale and extrudees to the centre, can be further makes the wound inwards extrude, further strengthens the hemostatic effect of wound.
Preferably, the intermediate layer is detachably connected with the inner layer, and the width of the intermediate layer is smaller than the width of the inner layer and the antibacterial hemostatic coating.
Through the arrangement, the disassembly connection between the middle layer and the inner layer can realize the recycling of the negative pressure sponge and the pressurizing air bag of the middle layer; the width of the middle layer is smaller than that of the inner layer and the antibacterial hemostatic coating, the inner layer and the antibacterial hemostatic coating can realize shielding protection on the middle layer, and pollution caused by wound blood stains is reduced, so that the antibacterial hemostatic coating can be reused after disinfection and sterilization.
Preferably, the lower side of the inner layer is made of bamboo charcoal fiber material and is made into a breathable isolation layer, the upper side of the inner layer is a waterproof layer, and the lower side of the air bag is bonded with the upper side of the waterproof layer.
Through the arrangement, the breathable isolation layer arranged on the inner side is beneficial to the ventilation of the wound, and the waterproof layer can prevent the blood stains of the wound from polluting the middle layer sponge after soaking the antibacterial hemostatic coating and the breathable isolation layer.
Preferably, the sponge of the intermediate layer is a sterile high density, high elasticity sponge.
Through the arrangement, the compression ratio is large under the negative pressure condition, the volume is large after the inhalation expansion, and the compression hemostasis effect on wounds is good.
Preferably, the antibacterial drug contained in the antibacterial hemostatic coating is erythromycin, and the hemostatic drug contained in the antibacterial hemostatic coating is one or two of phenol sulfoethylamine and Yunnan white drug powder.
By the arrangement, the wound is beneficial to preventing infection and stopping bleeding of the wound.
Preferably, the protective film is release paper made of silicone oil paper material.
Through the arrangement, the operation is convenient, and the use performance is reliable.
Preferably, the outer side of the outer layer is connected with a binding band around.
Through the arrangement, the operation is convenient.
Drawings
Fig. 1 is a top view of a negative pressure release hemostatic compression dressing of the present utility model;
FIG. 2 is a cross-sectional view of A-A of FIG. 1;
the names of the corresponding marks in the drawings are:
the anti-bacterial hemostatic coating comprises an outer layer 1, an intermediate layer 2, an inner layer 3, an anti-bacterial hemostatic coating 4, a protective film 5, a first valve 6, a binding belt 7, a regulating chamber 8 and a second valve 9.
Detailed Description
The utility model is described in further detail below with reference to the attached drawings and embodiments:
as shown in fig. 1 and 2, a negative pressure release type hemostasis by compression application comprises an outer layer 1, an intermediate layer 2, an inner layer 3 and an antibacterial hemostatic coating 4 from top to bottom in sequence, wherein the intermediate layer 2 is a sterile high-density and high-elasticity sponge in a negative pressure state, the intermediate layer 2 is communicated with a first valve 6, the first valve 6 is arranged on the outer side of the outer layer 1, the intermediate layer 2 is provided with a regulating cavity 8, the regulating cavity 8 is in a trapezoid shape with a large upper part and a small lower part, an air bag is adhered to the inner side wall of the regulating cavity 8, the air bag is communicated with a second valve 9, the second valve 9 is arranged on the outer side of the outer layer 1, the inner layer 3 is an isolation layer, the lower side of the inner layer 3 is a breathable isolation layer made of a bamboo charcoal fiber material, the upper side of the inner layer 3 is a waterproof layer, the lower side of the air bag is adhered to the upper side of the waterproof layer, the intermediate layer 2 on two sides of the air bag is also connected with the waterproof layer on the upper surface of the inner layer 3 in an adhering mode, the width of the intermediate layer 2 is smaller than the width of the inner layer 3 and the antibacterial hemostatic coating 4, the antibacterial hemostatic coating 4 contains erythromycin, the hemostatic drug is the phenolsulfoethylamine, the lower side of the hemostatic coating is adhered to the lower side of the hemostatic coating 4 is also adhered to the protective film 5 made of the outer layer 1.
The specific implementation process is as follows:
before the hemostatic plaster is used, the sterile high-density high-elasticity sponge of the middle layer 2 is in a negative pressure state, and the air bag in the adjusting chamber 8 is in an inflation and pressurization state; when the hemostatic plaster is used, the protective film 5 is taken down from the antibacterial hemostatic coating 4, the middle part of the antibacterial hemostatic coating 4 is aligned with the middle part of a wound of a patient, the whole hemostatic plaster is fixed on the wound by using the binding belt 7, and then the first valve 6 and the second valve 9 are opened, so that an air bag in the regulating cavity 8 is deflated, and the sterile high-density sponge of the middle layer 2 is inflated; the bandage 7 for fixing the whole hemostatic application is not changed, and the sponge of the middle layer 2 is inflated for realizing compression hemostasis of wounds; wherein, after the air bag in the regulating cavity 8 with the upper part being big and small and the lower part being deflated, the pressure of the sponge in the middle 2 disappears, the sponge which expands around expands towards the regulating cavity 8, so that the inner layer 3 and the hemostatic coating 4 are extruded towards the middle inner side, the inward extrusion of the wound is realized, and the hemostatic coating is beneficial to the hemostasis and recovery of the wound; the width of the middle layer 2 is smaller than that of the inner layer 3 and that of the hemostatic coating 4, the middle layer 2 and the inner layer 3 are connected in an adhesive mode, the inner layer 3 and the hemostatic coating 4 can effectively shield the middle layer 2 from being polluted by blood stains of wounds, and the hemostatic coating can be detached for reuse.
The hemostatic plaster has simple structure, has no requirements on the cleanliness and flatness of the periphery of the wound, and can be suitable for the wound of any part; and the negative pressure of the sponge in the middle layer 2 and the pressurization of the air bag are completed when the hemostatic plaster is prepared, and the expansion compression hemostasis can be realized without other equipment when the hemostatic plaster is used, so that the hemostatic plaster is applicable to outdoor or outdoor emergency hemostasis.
The foregoing is merely exemplary embodiments of the present utility model, and detailed technical solutions or features that are well known in the art have not been described in detail herein. It should be noted that, for those skilled in the art, several variations and modifications can be made without departing from the technical solution of the present utility model, and these should also be regarded as the protection scope of the present utility model, which does not affect the effect of the implementation of the present utility model and the practical applicability of the patent. The protection scope of the present utility model is subject to the content of the claims, and the description of the specific embodiments and the like in the specification can be used for explaining the content of the claims.
Claims (9)
1. The negative pressure release type compression hemostasis application is characterized by sequentially comprising an outer layer, a middle layer, an inner layer and an antibacterial hemostasis coating from outside to inside, wherein the middle layer is a sponge in a negative pressure state, the middle layer is communicated with a first valve, the first valve is arranged on the outer side of the outer layer, the inner layer is an isolation layer, and a protective film is adhered to the lower side of the antibacterial hemostasis coating.
2. A negative pressure release hemostatic compression dressing according to claim 1, wherein: the middle layer is provided with an adjusting cavity which is in a trapezoid shape with a large upper part and a small lower part, and the lower end face of the adjusting cavity is flush with the upper end face of the inner layer.
3. A negative pressure release hemostatic compression dressing according to claim 2, wherein: the inner side wall of the adjusting chamber is adhered with an air bag, the lower surface of the air bag is adhered with the upper end face of the inner layer, the air bag is communicated with a second valve, and the second valve is arranged on the outer side of the outer layer.
4. A negative pressure release hemostatic compression dressing according to claim 3, wherein: the middle layer is detachably connected with the inner layer, and the width of the middle layer is smaller than that of the inner layer and that of the antibacterial hemostatic coating.
5. A negative pressure release hemostatic compression dressing according to claim 4, wherein: the lower side of the inner layer is a breathable isolation layer made of bamboo carbon fiber materials, the upper side of the inner layer is a waterproof layer, and the lower side of the air bag is bonded with the upper side of the waterproof layer.
6. A negative pressure release hemostatic compression dressing according to claim 5, wherein: the sponge of the middle layer is sterile high-density and high-elasticity sponge.
7. A negative pressure release hemostatic compression dressing according to claim 1, wherein: the antibacterial drug contained in the antibacterial hemostatic coating is erythromycin, and the hemostatic drug contained in the antibacterial hemostatic coating is one or two of fensulfoethylamine and Yunnan white drug powder.
8. A negative pressure release hemostatic compression dressing according to claim 1, wherein: the protective film is release paper made of silicone oil paper materials.
9. A negative pressure release hemostatic compression dressing according to claim 1, wherein: the periphery of the outer side of the outer layer is connected with a binding belt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321123609.9U CN219847085U (en) | 2023-05-11 | 2023-05-11 | Negative pressure release type compression hemostasis application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321123609.9U CN219847085U (en) | 2023-05-11 | 2023-05-11 | Negative pressure release type compression hemostasis application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN219847085U true CN219847085U (en) | 2023-10-20 |
Family
ID=88333705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202321123609.9U Active CN219847085U (en) | 2023-05-11 | 2023-05-11 | Negative pressure release type compression hemostasis application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN219847085U (en) |
-
2023
- 2023-05-11 CN CN202321123609.9U patent/CN219847085U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110192905A (en) | A kind of tourniquet | |
| CN219847085U (en) | Negative pressure release type compression hemostasis application | |
| CN111296948A (en) | Medical mask with variable filtering area | |
| CN116831813A (en) | Negative pressure release type compression hemostasis application | |
| CN108969200A (en) | A kind of hospital gauze preventing adherency wound | |
| CN201061549Y (en) | Inflatable tourniquet | |
| CN210872475U (en) | Nasal mask for postoperative nursing of department of rhinology | |
| CN214967670U (en) | Trachea incision dressing paste | |
| CN211610346U (en) | Medical gauze dressing | |
| CN209984438U (en) | Pressure-adjustable adhesive dressing capable of preventing ascites puncture port from leaking and absorbing seepage | |
| CN205458886U (en) | Patient's four limbs wound hemostasis device | |
| CN211356252U (en) | Fixed cotton pad of knee joint replacement postoperative anti-drop pressurization | |
| CN211460369U (en) | Postoperative hemostasis nursing device for thoracic surgery rehabilitation | |
| CN209032784U (en) | A kind of multi-function plaster liner | |
| CN202105287U (en) | Tracheal tube protective pad | |
| CN214342945U (en) | Thyroid gland postoperative is with protection neck area | |
| CN217245756U (en) | Wound exudate plaster for closed drainage of thoracic cavity | |
| CN219480604U (en) | Waterproof breathable anti-infection vaccine needle eye protection hydrocolloid dressing | |
| CN219374806U (en) | Anticreep formula first aid tourniquet | |
| CN213283798U (en) | Band-aid capable of bending joints | |
| CN220193343U (en) | Double-medicine-patch type adhesive bandage | |
| CN213156150U (en) | Military embedded cheek hemostasis device | |
| CN212816768U (en) | A quick hemostasis device for department of general surgery's nursing | |
| CN108451580A (en) | A kind of Nephrology dept.'s hemostasis packet | |
| CN210250269U (en) | Nail bandage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |